Direct Total Iron Binding Capacity Reagent
- UID
- IMP/MD/2018/000187_fc76cd02a419071811882a0ea9765a24_778ed64c647b22141fa43a1f23d5df0d
- Device class
- Class B
- Brand name
- Transferrin, C3, C4, IgA, IgG, IgM
- License holder
- M/s. Ortho Clinical Diagnostics India Private Limited
- Approving authority
- CDSCO
- Product information
- For in vitro diagnostic use only VITROS Chemistry Products dTIBC Reagent is used on the VITROS Chemistry System and the VITROS Integrated System to quantitatively measure total iron-binding capacity (Transferrin, C3, C4, IgA, IgG, IgM) in human serum. The iron-binding capacity is useful in the differential diagnosis of anemia, iron deficiency anemia, thalassemia, sideroblastic anemia, and iron poisoning
Direct Total Iron Binding Capacity Reagent is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000187_fc76cd02a419071811882a0ea9765a24_778ed64c647b22141fa43a1f23d5df0d. This device is marketed under the brand name Transferrin, C3, C4, IgA, IgG, IgM. The license holder is M/s. Ortho Clinical Diagnostics India Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.